Body Composition Profile of Young Patients With Phenylketonuria and Mild Hyperphenylalaninemia

Authors Information
Article Notes and Dates
To Cite : Doulgeraki A, Skarpalezou A, Theodosiadou A, Monopolis I, Schulpis K. et al. Body Composition Profile of Young Patients With Phenylketonuria and Mild Hyperphenylalaninemia, Int J Endocrinol Metab. 2014 ;12(3):e16061. doi: 10.5812/ijem.16061.
Copyright: Copyright © 2014, International Journal of Endocrinology and Metabolism. .
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Scriver CR, Kaufman S. The metabolic and molecular bases of inherited disease. 2001; : 1667-724
  • 2. Blau N, Burgard P. Physician's guide to the treatment and follow-up of metabolic diseases. 2006; : 25-34[DOI]
  • 3. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr. 1996; 155 Suppl 1-8[PubMed]
  • 4. Weglage J, Pietsch M, Feldmann R, Koch HG, Zschocke J, Hoffmann G, et al. Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res. 2001; 49(4): 532-6[DOI][PubMed]
  • 5. Al-Qadreh A, Schulpis KH, Athanasopoulou H, Mengreli C, Skarpalezou A, Voskaki I. Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr. 1998; 87(11): 1162-6[PubMed]
  • 6. Crabtree NJ, Kibirige MS, Fordham JN, Banks LM, Muntoni F, Chinn D, et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone. 2004; 35(4): 965-72[DOI][PubMed]
  • 7. Chiotis D, Tsiftis G, Hatzisymeaon M, Maniati-Christidi M, Krikos X, Dacou Voutetakis A. Height and weight in subjects of Hellenic origin aged 0–18 years (2000–2001): comparison to a previous study of 1978–1979. Ann Cli Pediatr Univ Atheniensis. 2003; 350: 136-55
  • 8. Chiotis D, Krikos X, Tsiftis G, Hatzisymeaon M, Maniati-Christidi M, DacouVoutetakis A. Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0–18 years, living in the Athens area. Ann Clin Pediatr Univ Atheniensis. 2004; 51: 139-54
  • 9. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone. 2008; 43(6): 1115-21[DOI][PubMed]
  • 10. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child. 2002; 87(4): 341-7[PubMed]
  • 11. Taylor RW, Jones IE, Williams SM, Goulding A. Body fat percentages measured by dual-energy X-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in children and adolescents aged 3-18 y. Am J Clin Nutr. 2002; 76(6): 1416-21[PubMed]
  • 12. Albersen M, Bonthuis M, de Roos NM, van den Hurk DA, Carbasius Weber E, Hendriks MM, et al. Whole body composition analysis by the BodPod air-displacement plethysmography method in children with phenylketonuria shows a higher body fat percentage. J Inherit Metab Dis. 2010; 33 Suppl 3-8[DOI][PubMed]
  • 13. Belanger-Quintana A, Martinez-Pardo M. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study. Mol Genet Metab. 2011; 104(4): 480-4[DOI][PubMed]
  • 14. Lage S, Bueno M, Andrade F, Prieto JA, Delgado C, Legarda M, et al. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. J Inherit Metab Dis. 2010; 33 Suppl 3-71[DOI][PubMed]
  • 15. Adamczyk P, Morawiec-Knysak A, Pludowski P, Banaszak B, Karpe J, Pluskiewicz W. Bone metabolism and the muscle-bone relationship in children, adolescents and young adults with phenylketonuria. J Bone Miner Metab. 2011; 29(2): 236-44[DOI][PubMed]
  • 16. Porta F, Mussa A, Zanin A, Greggio NA, Burlina A, Spada M. Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia. J Pediatr Gastroenterol Nutr. 2011; 52(3): 345-50[DOI][PubMed]
  • 17. Greeves LG, Carson DJ, Magee A, Patterson CC. Fractures and phenylketonuria. Acta Paediatr. 1997; 86(3): 242-4[PubMed]
  • 18. Huemer M, Huemer C, Moslinger D, Huter D, Stockler-Ipsiroglu S. Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis. 2007; 30(5): 694-9[DOI][PubMed]
  • 19. Dobbelaere D, Michaud L, Debrabander A, Vanderbecken S, Gottrand F, Turck D, et al. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J Inherit Metab Dis. 2003; 26(1): 1-11[PubMed]
  • 20. Boye KR, Dimitriou T, Manz F, Schoenau E, Neu C, Wudy S, et al. Anthropometric assessment of muscularity during growth: estimating fat-free mass with 2 skinfold-thickness measurements is superior to measuring midupper arm muscle area in healthy prepubertal children. Am J Clin Nutr. 2002; 76(3): 628-32[PubMed]
  • 21. Jelastopulu E, Kallianezos P, Merekoulias G, Alexopoulos EC, Sapountzi-Krepia D. Prevalence and risk factors of excess weight in school children in West Greece. Nurs Health Sci. 2012; 14(3): 372-80[DOI][PubMed]
  • 22. Farajian P, Panagiotakos DB, Risvas G, Karasouli K, Bountziouka V, Voutzourakis N, et al. Socio-economic and demographic determinants of childhood obesity prevalence in Greece: the GRECO (Greek Childhood Obesity) study. Public Health Nutr. 2013; 16(2): 240-7[DOI][PubMed]
  • 23. Wells JC, Fewtrell MS. Measuring body composition. Arch Dis Child. 2006; 91(7): 612-7[DOI][PubMed]
  • 24. Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis. 2007; 30(2): 202-8[DOI][PubMed]
  • 25. Abadie V, Berthelot J, Feillet F, Maurin N, Mercier A, de Baulny HO, et al. Neonatal screening and long-term follow-up of phenylketonuria: the French database. Early Hum Dev. 2001; 65(2): 149-58[PubMed]
  • 26. Miras A, Boveda MD, Leis MR, Mera A, Aldamiz-Echevarria L, Fernandez-Lorenzo JR, et al. Risk factors for developing mineral bone disease in phenylketonuric patients. Mol Genet Metab. 2013; 108(3): 149-54[DOI][PubMed]
  • 27. Rocha JC, van Spronsen FJ, Almeida MF, Soares G, Quelhas D, Ramos E, et al. Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome. Mol Genet Metab. 2012; 107(4): 659-63[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check